CurrentmhnPolicy CP.MP.210

Repair of Nasal Valve Compromise

Medical necessity guidelines for surgical and procedural repair of nasal valve compromise (NVC) for members of the health plan; defines covered indications, required preconditions, and procedures considered investigational or not supported.

Policy Summary

Payermhn

PolicyRepair of Nasal Valve Compromise

Policy CodePolicy CP.MP.210

Change TypeMinor/technical (no material clinical changes)

Effective Date

Next Review Date

Key ActionObtain and document trials of conservative therapy (e.g., nasal cones, external nasal dilator adhesive strips, or a six‑week trial of nasal steroids) and confirm clinical findings such as Cottle maneuver response before requesting authorization for repair.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1Covered CPT code listed

2CPT codes not supporting coverage

4Core clinical criteria items required

3Procedures with insufficient evidence

Coverage Criteria for Repair of Nasal Valve Compromise

Medically necessary repair of nasal valve compromise

Covered when ALL of the following are met:

I.A Clinical findings: Clinical findings of one or more of: internal valve collapse or compromise of the upper lateral cartilage; OR external nasal valve compromise due to collapse of the lower lateral cartilage.

I.B Symptom correlation: Complaints of obstructed breathing that resolve with the Cottle maneuver or with lateralization of the upper lateral cartilage from inside the nose using an object (examples: cotton swab, nasal speculum, outpatient nocturnal trial of external stents such as Breathe Right nasal strips, or outpatient nocturnal trial of nasal dilators such as Max‑Air Nose Cones or Sinus Cones).

I.C Rule out other causes: Other causes of obstructed breathing have been ruled out (examples: sinusitis, allergic rhinitis, nonallergic rhinitis, nasal polyps, adenoid hypertrophy, nasopharyngeal masses, septal deviation, and turbinate hypertrophy).

Policy Summary

Payermhn

PolicyRepair of Nasal Valve Compromise

Policy CodePolicy CP.MP.210

Change TypeMinor/technical (no material clinical changes)

Effective Date

Next Review Date

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

This policy identifies several procedures for repair of nasal vestibular stenosis that do not have established safety and efficacy and therefore are not supported. Specifically, the policy lists radiofrequency ablation (VivAer®), absorbable lateral wall implants (Latera®), and nasal valve suspension surgery as procedures with insufficient evidence to be considered standard care for nasal valve compromise. The VivAer procedure is an office‑based, low‑dose radiofrequency technique intended to remodel intranasal soft tissues by creating controlled coagulation lesions that stiffen tissue as they heal, but available studies are limited in quality and do not clearly demonstrate objective improvements in nasal airflow. The Latera implant is an absorbable PLLA‑PDLA lateral wall support placed endonasally and designed to be replaced by a fibrous matrix over about 12–18 months; however, its safety and long‑term effectiveness remain inadequately established in the evidence base. Due to these limitations, the policy treats these approaches as investigational for repair of nasal vestibular stenosis.

Coverage is limited to procedures meeting the policy’s medical necessity criteria; procedures billed with CPT 30468 or 30469 are listed as not supporting coverage. CPT 30468 describes repair with subcutaneous/submucosal lateral wall implant(s) and corresponds to absorbable implant approaches such as Latera, while CPT 30469 describes low‑energy, temperature‑controlled radiofrequency subcutaneous/submucosal remodeling, corresponding to procedures like VivAer. The policy explicitly states that VivAer, absorbable implants, and nasal valve suspension surgery lack sufficient established safety and efficacy for repair of nasal vestibular stenosis and thus are not supported for coverage under this policy.

Provider Requirements and Prior Authorization

Prior Authorization

Prior Authorization and Coding

Prior authorization required for repair of nasal vestibular stenosis when coverage criteria are met. Ensure the request is coded to the supporting CPT and includes required clinical documentation (see documentation callout).

Submit prior authorization referencing CPT 30465 when clinical criteria for repair of nasal vestibular stenosis are satisfied.
Include clinical findings (internal or external valve collapse), response to Cottle maneuver or lateralization testing, and documentation of a trial of conservative therapy.

Step Therapy

Conservative Therapy Required

A documented trial of conservative therapies is required and must be included with the prior authorization request. Examples of acceptable conservative treatments are provided below; duration and response should be noted.

Trial of nasal cones (e.g., Max-Air Nose Cones®, Sinus Cones®) or external nasal dilator adhesive strips (e.g., Breathe Right®).
Outpatient nocturnal trial of external stents or nasal dilators and/or a six-week trial of intranasal corticosteroids.
Document duration and patient response to conservative measures in the chart and with the authorization request.

Documentation Required

Required Clinical Documentation

Include objective and procedural findings to support medical necessity. At a minimum, document the type of valve compromise, results of Cottle maneuver or lateralization testing, and details of conservative therapy tried.

Document internal valve collapse or compromise of the upper lateral cartilage, or external valve compromise from lower lateral cartilage collapse.
Record positive response to the Cottle maneuver, Bachman’s maneuver, or lateralization testing (e.g., improved nasal airflow with manual lateralization or instrument simulation).
Include NOSE score, nasal endoscopy or anterior rhinoscopy findings, and results of any nasal decongestant testing or objective airflow measures when available.

Denial Risk

Unsupported CPT Codes — Denial Risk

Do not submit requests for repair of nasal valve compromise under CPT codes that do not support coverage; such requests may be denied.

CPT 30468 (repair with subcutaneous/submucosal lateral wall implant[s]) is not a covered code for this indication.
CPT 30469 (low energy/temperature-controlled radiofrequency subcutaneous/submucosal remodeling, e.g., VivAer®) is not supported and may be denied.

Background

Nasal valve compromise (NVC) is a structural narrowing of the nasal passage that can produce symptomatic obstructed breathing. Clinically, NVC may result from internal valve collapse involving the upper lateral cartilage or external nasal valve compromise due to collapse of the lower lateral cartilage. Diagnosis relies on history and focused physical examination maneuvers (for example, the Cottle maneuver or manual lateralization of the upper lateral cartilage), symptom correlation, and exclusion of other causes of obstruction. The policy requires documentation that symptoms correlate with valve findings and persist despite conservative measures before considering surgical repair.

Definitions

Nasal valve compromise (NVC) — definition of condition

DefinitionNasal valve compromise (NVC), also known as nasal valve collapse, is a narrowing of the nasal passageway causing difficult, obstructed breathing due to collapse or weakness of internal or external nasal valve structures.

Common causesStructural weakness or collapse from injury or trauma, prior nasal surgery, chronic inflammation, congenital defects, or aging.

Associated conditionsMay present with or be exacerbated by rhinitis, sinusitis, septal deviation, or adenoid hypertrophy.

Typical symptomsDifficulty inhaling through the nose, sensation of congestion, stuffiness or blockage, nasal bleeding, and snoring.

VivAer (Aerin) procedure — definition / description

Procedure descriptionThe Aerin VivAer procedure is a non‑invasive, office‑based treatment that uses low‑dose radiofrequency (RF) energy to modify intranasal soft tissues with the intent of improving airflow in patients with nasal valve collapse.

Mechanism of actionThe system maintains a target temperature while sparing surrounding mucosa, creates coagulation lesions that heal with tissue retraction and stiffening to reduce obstruction and airflow resistance.

Device componentsConsists of a console and two styluses (one for nasal airway obstruction and one for chronic rhinitis).

Evidence summaryClinical studies reviewed provide minimal support; studies suggest safety and possible patient‑reported symptom improvement but limited objective evidence and no comparisons to active treatments.

Latera absorbable implant — definition / description

Device descriptionLatera is an absorbable lateral wall nasal implant composed of a PLLA‑PDLA copolymer placed endonasally to support upper and lower lateral wall cartilage.

Placement and anesthesiaPlaced via an endonasal access point using a 16‑gauge cannula, typically under general anesthesia.

Duration and biologic responseOver ~12 months the implant becomes enveloped by fibrous tissue; by ~18 months the implant is absorbed and replaced with a fibrous collagen matrix that provides continued support.

System componentsIncludes the absorbable implant, delivery device, and an implant positioning guide as an external visual planning aid prior to placement.

OpenPayer

Repair of Nasal Valve Compromise

Coverage Criteria for Repair of Nasal Valve Compromise

CPT Codes and Coding Guidance

Provider Requirements and Prior Authorization

Background

Definitions

30468	Repair of nasal valve collapse with subcutaneous/submucosal lateral wall implant(s).
30469	Repair of nasal valve collapse with low energy, temperature-controlled (i.e., radiofrequency) subcutaneous/submucosal remodeling